Speakers

Jesús Martínez de la Fuente
Material Science Institute of Aragón - Novel nanomaterials and their subsequent biofunctionalization for the use and development of next generation nanobiosensors and nanotherapeutics.
View website
Pablo Menendez
Stem cell biology, developmental leukemia & immunotherapy Lab. Josep Carreras Leukaemia Research Institute
View website
Olalla Váquez
Photochemical Control of Biological Processes
View website
Eva M Galan Moya
Centro Regional de Investigaciones Biomédicas de la U. de Castilla-La Mancha. Development of strategies to overcome resistance to anticancer drugs. Study of cancer cell plasticity and tumor microenvironment.
View website
Santiago Nonell
University Ramon Llull - The research focus on biológica photochemistry, photodynamic therapies and theranostic applications with lights.
View website
Santiago de la Moya
Universidad Complutense de Madrid - Synthetic development and key photophysical and chemical features of novel BODIPY-dye designs as smart platforms for advancing phototheragnosis.
View website
Lluis Montoliu
Centro Nacional de Biotecnología (CNB-CSIC). Function and organization of genes in the mammalian genome and the necessary regulatory elements that identify a given expression domain and specify its expression pattern in space, time and quantity.
View website
Laura Soucek
Vall d'Hebron Institute of Oncology A first-in-class mini-protein against MYC as a novel cancer therapy
View website
Miguel Ángel Miranda
His main contribution are focus on the development of the molecular bases of drug photosensitization (phototoxicity, photoallergy, photogenotoxicity) and the strategies for photoprotection and photorepair.
View website
Marcelo Calderón
POLYMAT - Nanogels as smart polymeric systems for the improvement of the therapeutic index of drugs.
View website
Gloria Gonzalez Aseguinolaza
Centro de Investigaciones Clínicas Aplicadas de Un. Navarra. Development of gene therapy vectors and strategies to modulate the immune response against them. Study of the mechanisms involved in the development of hereditary and acquired liver diseases.
View website
Amadeu Llebaria
Institute for Advanced Chemistry - Photopharmacology, control of the activity of therapeutic compounds by means of light can be achieved with photolabile compounds.
View website
Nuria Camarero
Instituto de Bioingeniería de Cataluña
View website
Didier Berthelot
Principal Scientist at Janssen, Pharmaceutical Companies of Johnson and Johnson. A proteolysis targeting chimera (PROTAC) and their applications
View website